OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
30
Results
Show all
Save search
Copy query
Show results for
Unknown
(30)
Publication Date
Release Date
2022
(6)
2021
(6)
2024
(4)
2023
(3)
2013
(3)
2011
(2)
2010
(2)
2025
(1)
2017
(1)
2016
(1)
2008
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Antibiotics as first-line alternative to appendicectomy in adult appendicitis: 90-day follow-up from a prospective, multicentre cohort study.
Not available
S-EPMC8499866
|
biostudies-literature
Cite
Results of the two incidence screenings in the National Lung Screening Trial.
Not available
S-EPMC4307922
|
biostudies-literature
Cite
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Not available
S-EPMC4356534
|
biostudies-literature
Cite
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Not available
S-EPMC5200636
|
biostudies-literature
Cite
Arthroplasty-CervicalP001 - Double Crush Syndrome of the Vertebral Artery Loop and Foraminal Stenosis Causing Monoparesis
Not available
S-EPMC5724662
|
biostudies-literature
Cite
The National Lung Screening Trial: overview and study design.
Not available
S-EPMC3009383
|
biostudies-literature
Cite
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.
Not available
S-EPMC2911350
|
biostudies-literature
Cite
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Not available
S-EPMC3670748
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets